GlassScriptPhysician profile
Lawrence Scott Levin
NPI 1972666741
$80,274.62
in general payments reported to CMS, 2019-2025
14 companies · $9,407 in 2025
The $9,407 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,843 · 2020: $415 · 2022: $308 · 2023: $16K · 2024: $49K · 2025: $9,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $19K · Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,885.00 |
| Travel and Lodging | $19,292.56 |
| Food and Beverage | $531.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Microinstruments, INC. | $48,000.00 | 2024 | Symani Surgical Systems |
| Bonebridge INC. | $21,552.56 | 2023-2025 | |
| Medartis INC. | $4,790.36 | 2019 | |
| Checkpoint Surgical, INC | $4,626.50 | 2022-2023 | Checkpoint Stimulators |
| Edwards Lifesciences Corporation | $400.00 | 2020 | |
| Integra Lifesciences Corporation | $244.35 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $145.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Rti Surgical, INC | $135.41 | 2025 | |
| Goode Surgical INC | $124.84 | 2022 | |
| Arthrex, INC. | $116.99 | 2025 | |
| Smith+Nephew, INC. | $91.69 | 2019-2023 | Pico 7 |
| Medela LLC | $18.08 | 2019 | |
| Djo, LLC | $14.86 | 2019 | |
| Endo USA, INC. | $13.90 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.